Cargando…

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis

Non-alcoholic fatty liver disease (NAFLD), is a disease spectrum characterized by fat accumulation in hepatocytes presenting as hepatic steatosis to advance disease with active hepatic inflammation, known as nonalcoholic steatohepatitis. Chronic steatohepatitis will lead to progressive hepatic fibro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seen, Tasur Kumar, Sayed, Muntazir, Bilal, Muhammad, Reyes, Jonathan Vincent, Bhandari, Priyanka, Lourdusamy, Vennis, Al-khazraji, Ahmed, Syed, Umer, Sattar, Yasar, Bansal, Raghav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218360/ https://www.ncbi.nlm.nih.gov/pubmed/34163108 http://dx.doi.org/10.3748/wjg.v27.i23.3238

Ejemplares similares

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

A Case of Gastric Emphysema: Incidental Findings or Serious Illness
por: Reyes, Jonathan Vincent, et al.
Publicado: (2020)

Cystic Artery Pseudoaneurysm Secondary to Cholecystitis: A Rare Cause of Hemobilia
por: Khan, Haidar, et al.
Publicado: (2023)

Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
por: Sinakos, Emmanouil, et al.
Publicado: (2022)

Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis–Related Cirrhosis With Liraglutide
por: Yuen, Christina, et al.
Publicado: (2023)

Diagnosis and management of unilateral subclavian steal syndrome with bilateral carotid artery stenosis
por: Song, David, et al.
Publicado: (2021)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2022)

Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
por: Suri, Jaspreet, et al.
Publicado: (2022)

An obese patient with acute cholecystitis, nonalcoholic steatohepatitis and cirrhosis: A case report
por: Zuiki, Toru, et al.
Publicado: (2020)

Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?
por: Cao, Ying, et al.
Publicado: (2020)

Muscular abnormalities in liver cirrhosis
por: Hari, Andrej
Publicado: (2021)

Anemia in cirrhosis: An underestimated entity
por: Manrai, Manish, et al.
Publicado: (2022)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Implication of the intestinal microbiome in complications of cirrhosis
por: Bhat, Mamatha, et al.
Publicado: (2016)

New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
por: Jamshed, Fatima, et al.
Publicado: (2023)

Aortic stenosis and Heyde’s syndrome: A comprehensive review
por: Lourdusamy, Dennisdhilak, et al.
Publicado: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
por: Zhai, Mimi, et al.
Publicado: (2021)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2023)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis
por: Kram, Michael
Publicado: (2023)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Nutritional evaluation in cirrhosis: Emphasis on the phase angle
por: Fernandes, Sabrina Alves, et al.
Publicado: (2016)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
por: Yalniz, Mehmet, et al.
Publicado: (2006)

Extended spectrum beta lactamase producing Escherichia coli eustachian valve infective endocarditis
por: Ireifej, Branden, et al.
Publicado: (2021)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

A Rare Presentation of Sarcomatoid Carcinoma of Duodenum: A Case Report
por: Reyes, Jonathan Vincent, et al.
Publicado: (2022)

Typhlitis: A Rare Appendicitis Mimic in a Young Healthy Female
por: Reyes, Jonathan Vincent M, et al.
Publicado: (2021)

Management of refractory ascites in cirrhosis: Are we out of date?
por: Annamalai, Alagappan, et al.
Publicado: (2016)

Spectrum of esophageal motility disorders in patients with liver cirrhosis
por: Khalaf, Mohamed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tkkplie64knsbq77muk56mc6qf